• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases

tetano

Editor, Senior Moderator
Viruses


. 2021 Mar 19;13(3):512.
doi: 10.3390/v13030512.
Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases


Szil?rd V?ncsa[SUP] 1 2 [/SUP], Fanni Dembrovszky[SUP] 1 2 [/SUP], Nelli Farkas[SUP] 1 2 3 [/SUP], Lajos Szak?[SUP] 1 2 [/SUP], Brigitta Teutsch[SUP] 1 2 [/SUP], Stefania Bunduc[SUP] 1 4 5 [/SUP], Rita Nagy[SUP] 1 6 [/SUP], Andrea P?rniczky[SUP] 1 2 6 7 [/SUP], B?lint Er?ss[SUP] 1 2 [/SUP], Zolt?n P?terfi[SUP] 8 [/SUP], P?ter Hegyi[SUP] 1 2 [/SUP]



Affiliations

Abstract

Repeated positivity and reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is a significant concern. Our study aimed to evaluate the clinical significance of repeatedly positive testing after coronavirus disease 2019 (COVID-19) recovery. We performed a systematic literature search following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. With available individual patient data reporting on repeatedly SARS-CoV-2 positive (RSP) patients, case reports, and case series were included in this analysis. We performed a descriptive analysis of baseline characteristics of repeatedly positive cases. We assessed the cases according to the length of their polymerase chain reaction (PCR) negative interval between the two episodes. Risk factors for the severity of second episodes were evaluated. Overall, we included 123 patients with repeated positivity from 56 publications, with a mean repeated positivity length of 47.8 ? 29.9 days. Younger patients were predominant in the delayed (>90 days) recurrent positive group. Furthermore, comparing patients with RSP intervals of below 60 and above 60 days, we found that a more severe disease course can be expected if the repeated positivity interval is shorter. Severe and critical disease courses might predict future repeatedly positive severe and critical COVID-19 episodes. In conclusion, our results show that the second episode of SARS-CoV-2 positivity is more severe if it happens within 60 days after the first positive PCR. On the other hand, the second episode's severity correlates with the first.

Keywords: COVID-19; SARS-CoV-2; case reports; new coronavirus; polymerase chain reaction; positive; repeated; systematic review.
 
Back
Top Bottom